Trial Profile

A double-blind, placebo-controlled evaluation of dose related safety and efficacy of epicutaneously applied IDEA-033 [ketoprofen] for 3 months treatment of OA [osteoarthritis] of the knee followed by a double-blind, dose-controlled evaluation of safety and efficacy of epicutaneously applied IDEA-033 for 12 weeks treatment of OA of the knee

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 11 Apr 2009

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Nov 2008 Results were presented at EULAR 2008. Actual patient numbers added. Link to ADNM 801116646 added.
14 Jun 2007 Results data presented at EULAR 2007 (1078891).
23 Nov 2006 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com